Jason O'Byrne

EVP & Chief Financial Officer

EVP & Chief Financial Officer at Vir Biotechnology, Inc., filing insider transactions between 2026-02-23 and 2026-02-24.

Total Purchases

—

0 transactions

Total Sales

$31K

2 transactions

Companies Traded

2 total filings

Active Since

2026-02-23

Last: 2026-02-24

Companies

Vir Biotechnology, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-02-24	VIR	Sale	1,634	$9.53	$16K	162.6K	SEC ↗
2026-02-23	VIR	Sale	2,089	$7.45	$16K	164.2K	SEC ↗